Skip to main content
Top
Published in: Journal of Cancer Education 4/2012

01-12-2012

Breast Cancer Treatment of Women with Schizophrenia and Bipolar Disorder from Philadelphia, PA: Lessons Learned and Suggestions for Improvement

Authors: Marion Cole, Aruna Padmanabhan

Published in: Journal of Cancer Education | Issue 4/2012

Login to get access

Abstract

Treating cancer in patients with concurrent severe mental illness is complex and challenging for patients, families, and health care providers. Two such illnesses include schizophrenia and bipolar disorder. In this review, cases of women with breast cancer and severe mental illness from Philadelphia, PA illustrate the obstacles these women face in maintaining adequate cancer care. Barriers to receiving cancer treatment include understanding their disease, continuing medications and appointments, and experiencing complications of their psychiatric disorders. Learning from these cases is critical for health care providers and allows for innovation in treating and educating this difficult population. Increasing patient visit time, using social support services, and psychiatrist and psychiatrist-liaisons are necessary to improve care. In addition, family or caregivers should be included in discussions when possible. These techniques will assist in educating patients, improve insight into their disease and treatment, and allow them to benefit from cancer therapy.
Literature
1.
go back to reference Howard LM, Barley EA, Davies E, Rigg A, Lempp H, Rose D, Taylor D, Thornicroft G (2010) Cancer diagnosis in people with severe mental illness: practical and ethical issues. Lancet 11:797–804CrossRef Howard LM, Barley EA, Davies E, Rigg A, Lempp H, Rose D, Taylor D, Thornicroft G (2010) Cancer diagnosis in people with severe mental illness: practical and ethical issues. Lancet 11:797–804CrossRef
2.
go back to reference Moini B, Levenson JL (2009) A forgotten diagnosis: simple schizophrenia in a patient with breast cancer. Psychosomatics 50(1):87–89PubMedCrossRef Moini B, Levenson JL (2009) A forgotten diagnosis: simple schizophrenia in a patient with breast cancer. Psychosomatics 50(1):87–89PubMedCrossRef
3.
go back to reference BarChana M, Levav I, Lipshitz I, Pugachova I, Kohn R, Weizman A, Grinshpoon A (2008) Enhanced cancer risk among patients with bipolar disorder. J Affect Disord 108:43–48PubMedCrossRef BarChana M, Levav I, Lipshitz I, Pugachova I, Kohn R, Weizman A, Grinshpoon A (2008) Enhanced cancer risk among patients with bipolar disorder. J Affect Disord 108:43–48PubMedCrossRef
4.
go back to reference Hodgson R, Wildgust HJ, Bushe CJ (2010) Cancer and schizophrenia: is there a paradox? J Psychopharmacol 24(11 Supplement 4):51–60PubMedCrossRef Hodgson R, Wildgust HJ, Bushe CJ (2010) Cancer and schizophrenia: is there a paradox? J Psychopharmacol 24(11 Supplement 4):51–60PubMedCrossRef
5.
go back to reference Inagaki T, Yasukawa R, Okazaki S, Yasuda H, Kawamukai T, Utani E, Hayashida M, Mizuno S, Miyaoka T, Shinno H, Horiguchi J (2006) Factors disturbing treatment for cancer in patients with schizophrenia. Psychiatry Clin Neurosci 60:327–331PubMedCrossRef Inagaki T, Yasukawa R, Okazaki S, Yasuda H, Kawamukai T, Utani E, Hayashida M, Mizuno S, Miyaoka T, Shinno H, Horiguchi J (2006) Factors disturbing treatment for cancer in patients with schizophrenia. Psychiatry Clin Neurosci 60:327–331PubMedCrossRef
6.
go back to reference Fair AM, Wujcik D, Lin JS, Zhen W, Egan KM, Grau AM, Champion VL, Wallston KA (2010) Psychosocial determinants of mammography follow-up after receipt of abnormal mammography results in medically underserved women. J Health Care Poor Underserved 21(1 Suppl):71–94PubMed Fair AM, Wujcik D, Lin JS, Zhen W, Egan KM, Grau AM, Champion VL, Wallston KA (2010) Psychosocial determinants of mammography follow-up after receipt of abnormal mammography results in medically underserved women. J Health Care Poor Underserved 21(1 Suppl):71–94PubMed
7.
go back to reference Blanchard J, Ogle K, Thomas O, Lung D, Asplin B, Lurie N (2008) Access to appointments based on insurance status in Washington, D.C. J Health Care Poor Underserved 19(3):687–696PubMedCrossRef Blanchard J, Ogle K, Thomas O, Lung D, Asplin B, Lurie N (2008) Access to appointments based on insurance status in Washington, D.C. J Health Care Poor Underserved 19(3):687–696PubMedCrossRef
8.
go back to reference McWilliams S, Hill S, Mannion N, Fetherston A, Kinsella A, O’Callaghan E (2012) Schizophrenia: a five-year follow-up of patient outcome following psycho-education for caregivers. Eur Psychiatry 27(1):56–61PubMedCrossRef McWilliams S, Hill S, Mannion N, Fetherston A, Kinsella A, O’Callaghan E (2012) Schizophrenia: a five-year follow-up of patient outcome following psycho-education for caregivers. Eur Psychiatry 27(1):56–61PubMedCrossRef
9.
go back to reference Han WT, Collie K, Koopman C, Azarow J, Classen C, Morrow GR, Michel B, Brennan-O’Neill E, Spiegel D (2005) Breast cancer and problems with medical interactions: relationships with traumatic stress, emotional self-efficacy, and social support. Psychooncology 14(4):318–330PubMedCrossRef Han WT, Collie K, Koopman C, Azarow J, Classen C, Morrow GR, Michel B, Brennan-O’Neill E, Spiegel D (2005) Breast cancer and problems with medical interactions: relationships with traumatic stress, emotional self-efficacy, and social support. Psychooncology 14(4):318–330PubMedCrossRef
Metadata
Title
Breast Cancer Treatment of Women with Schizophrenia and Bipolar Disorder from Philadelphia, PA: Lessons Learned and Suggestions for Improvement
Authors
Marion Cole
Aruna Padmanabhan
Publication date
01-12-2012
Publisher
Springer-Verlag
Published in
Journal of Cancer Education / Issue 4/2012
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-012-0391-7

Other articles of this Issue 4/2012

Journal of Cancer Education 4/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine